Merck Adjusts Sales Forecast Amid Slowing Demand for Gardasil Vaccine in China
2 months ago
In a recent update, Merck & Co. has revised its sales outlook downward, largely attributed to subpar demand for its Gardasil vaccine in the Chinese market. The pharmaceutical giant is now bracing for a potential decline in sales as the uptake of their human papillomavirus (HPV) vaccine fails to meet projections.
Continue reading
GSK's Vaccine Sales Decline Dims Profit Outlook Despite Strong Earnings
2 months ago
GlaxoSmithKline (GSK), the prominent British pharmaceutical giant, has reported a noticeable drop in its vaccine sales, which has raised concerns over future profitability. Despite achieving strong profits in the third quarter, the company’s reduced sales in the vaccines sector are overshadowing these positive financial results, signaling potential challenges ahead for one of its key revenue streams.
Continue reading